Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

被引:0
|
作者
Cornish, Elisa Eleanor [1 ,2 ]
Teo, Kelvin Yi Chong [1 ,3 ]
Gillies, Mark C. [1 ,2 ]
Lim, Lyndell L. [4 ]
McAllister, Ian [5 ]
Sanmugasundram, Sutha [4 ]
Vuong Nguyen [2 ]
Wickremasinghe, Sanjeewa [4 ]
Mehta, Hemal [6 ]
Fraser-Bell, Samantha [1 ,2 ]
机构
[1] Sydney Eye Hosp, Ophthalmol, Sydney, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Save Sight & Eye Hlth Inst, Sydney, NSW, Australia
[3] Singapore Natl Eye Ctr, Singapore, Singapore
[4] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[5] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA, Australia
[6] Royal Free London NHS Fdn Trust, Ophthalmol, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4847
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema
    Sheth, Saumil
    Rush, Ryan
    Natarajan, Sundaram
    Gillies, Mark
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (07): : 673 - 681
  • [22] Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema
    Cornish, Elisa E.
    Teo, Kelvin Y. C.
    Gillies, Mark C.
    Lim, Lyndell L.
    Nguyen, Vuong
    Wickremasinghe, Sanjeewa
    Mehta, Hemal
    McAllister, Ian L.
    Fraser-Bell, Samantha
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (01) : 79 - 83
  • [23] INTRAVITREAL DEXAMETHASONE IMPLANT VERSUS INTRAVITREAL BEVACIZUMAB DURING CATARACT SURGERY FOR THE MANAGEMENT OF DIABETIC MACULOPATHY IN REMOTE INDIGENOUS COMMUNITIES: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Liu, Ebony
    Kaidonis, Georgia
    Henderson, Tim
    Lake, Stewart
    Mills, Richard
    Craig, Jamie
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 136 - 137
  • [24] Intravitreal Bevacizumab for Neovascular Glaucoma A Randomized Controlled Trial
    Yazdani, Shahin
    Hendi, Kamran
    Pakravan, Mohammad
    Mahdavi, Manijeh
    Yaseri, Mehdi
    JOURNAL OF GLAUCOMA, 2009, 18 (08) : 632 - 637
  • [25] A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema
    Scott, Ingrid U.
    Edwards, Allison R.
    Beck, Roy W.
    Bressler, Neil M.
    Chan, Clement K.
    Elman, Michael J.
    Friedman, Scott M.
    Greven, Craig Michael
    Maturi, Raj K.
    Pieramici, Dante J.
    Shami, Michel
    Singerman, Lawrence J.
    Stockdale, Cynthia R.
    OPHTHALMOLOGY, 2007, 114 (10) : 1860 - 1867
  • [26] A Prospective Randomized Trial of Intravitreal Bevacizumab Versus Ranibizumab for the Management of Diabetic Macular Edema
    Nepomuceno, Antonio Brunno
    Takaki, Erika
    Paes de Almeida, Felipe Piacentini
    Peroni, Renato
    Cardillo, Jose Augusto
    Siqueira, Rubens Camargo
    Scott, Ingrid Ursula
    Messias, Andre
    Jorge, Rodrigo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (03) : 502 - 510
  • [27] Comparison of Intravitreal Bevacizumab Alone or Combined with Triamcinolone versus Triamcinolone in Diabetic Macular Edema: A Randomized Clinical Trial
    Lim, Ji Won
    Lee, Hyo Kyoung
    Shin, Min Cheol
    OPHTHALMOLOGICA, 2012, 227 (02) : 100 - 106
  • [28] Multicenter, Randomized Clinical Trial to Assess the Effectiveness of Intravitreal Injections of Bevacizumab, Triamcinolone, or Their Combination in the Treatment of Diabetic Macular Edema
    Neto, Hermelino O.
    Regatieri, Caio V.
    Nobrega, Mario J.
    Muccioli, Cristina
    Casella, Antonio M.
    Andrade, Rafael E.
    Maia, Mauricio
    Kniggendorf, Vinicius
    Ferreira, Magno
    Branco, Andre C.
    Belfort, Rubens, Jr.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (09): : 734 - 740
  • [29] INTRAVITREAL BEVACIZUMAB PLUS BRINZOLAMIDE VERSUS INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY: PILOT STUDY
    Ramon Alvarez-Felix, Jesus
    Karla, Pimentel
    Paz, Silvia
    Chavez Romero, Yolanda
    Ramon, Abel
    Magana, David
    Sital-Gastelum, Sergio
    Romo-Garcia, Efrain
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [30] Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial
    Nader Baharivand
    Ali Mahdavifard
    Rohollah Fadaei Fouladi
    International Ophthalmology, 2013, 33 : 39 - 46